Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03275103
Brief Title: Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

First Submitted : September 5, 2017
First Submitted that Met QC Criteria : September 5, 2017
First Posted : September 7, 2017

Last Update Submitted that Met QC Criteria : June 4, 2021
Last Update Posted : June 7, 2021